GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inspire Medical Systems Inc (NYSE:INSP) » Definitions » Intrinsic Value: Projected FCF

Inspire Medical Systems (Inspire Medical Systems) Intrinsic Value: Projected FCF : $4.67 (As of Apr. 27, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Inspire Medical Systems Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-04-27), Inspire Medical Systems's Intrinsic Value: Projected FCF is $4.67. The stock price of Inspire Medical Systems is $237.45. Therefore, Inspire Medical Systems's Price-to-Intrinsic-Value-Projected-FCF of today is 50.9.

The historical rank and industry rank for Inspire Medical Systems's Intrinsic Value: Projected FCF or its related term are showing as below:

INSP' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 42.76   Med: 43.16   Max: 50.96
Current: 50.85

During the past 9 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Inspire Medical Systems was 50.96. The lowest was 42.76. And the median was 43.16.

INSP's Price-to-Projected-FCF is ranked worse than
99.13% of 345 companies
in the Medical Devices & Instruments industry
Industry Median: 1.67 vs INSP: 50.85

Inspire Medical Systems Intrinsic Value: Projected FCF Historical Data

The historical data trend for Inspire Medical Systems's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inspire Medical Systems Intrinsic Value: Projected FCF Chart

Inspire Medical Systems Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only - - - 5.89 4.67

Inspire Medical Systems Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.89 1.32 2.46 2.91 4.67

Competitive Comparison of Inspire Medical Systems's Intrinsic Value: Projected FCF

For the Medical Devices subindustry, Inspire Medical Systems's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inspire Medical Systems's Price-to-Projected-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inspire Medical Systems's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Inspire Medical Systems's Price-to-Projected-FCF falls into.



Inspire Medical Systems Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Inspire Medical Systems's Free Cash Flow(6 year avg) = $-21.55.

Inspire Medical Systems's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Dec23)*0.8)/Shares Outstanding (Diluted Average)
=(14.862653310476*-21.54528+572.514*0.8)/29.520
=4.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Inspire Medical Systems  (NYSE:INSP) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Inspire Medical Systems's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=237.45/4.6677226586338
=50.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Inspire Medical Systems Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Inspire Medical Systems's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Inspire Medical Systems (Inspire Medical Systems) Business Description

Traded in Other Exchanges
Address
5500 Wayzata Boulevard, Suite 1600, Golden Valley, MN, USA, 55416
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Executives
Timothy P. Herbert director, 10 percent owner, officer: CEO and President C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Jerry C Griffin director 887L INDUSTRIAL ROAD, SAN CARLOS CA 94070
Carlton Weatherby officer: Chief Strategy Officer C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Steven Jandrich officer: Chief Comp Off & VP, Human Res C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Philip Ebeling officer: Chief Operating Officer INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600, GOLDEN VALLEY MN 55416
John Rondoni officer: Chief Technology Officer C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Richard Buchholz officer: Chief Financial Officer C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Randy Ban officer: Senior VP. & Sales & Marketing C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Marilyn C Nelson director C/O EXXON MOBIL CORP, 5959 LAS COLINAS BLVD., IRVING TX 75039-2298
Cynthia Burks director C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Charisse Y Sparks director C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Georgia Melenikiotou director C/O INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BOULEVARD, SUITE 1600, GOLDEN VALLEY MN 55416
Bryan K Phillips officer: See Remarks 9924 WEST 74TH STREET, EDEN PRAIRIE MN 55344
Shelley G. Broader director 880 CARILLON PARKWAY, ST. PETERSBURG FL 33702
Casey M Tansey director, 10 percent owner 2735 SAND HILL ROAD, MENLO PARK CA 94025

Inspire Medical Systems (Inspire Medical Systems) Headlines

From GuruFocus